| 17.42% | $714 B | 3359 | $752.55 | $2.53 M | Healthcare | Drug Manufacturers - General | United States |
| 7.14% | $116 B | 18 K | $57.05 | $1.01 M | Healthcare | Drug Manufacturers - General | United States |
| 6.69% | $197 B | 9597 | $98.69 | $947.13 K | Healthcare | Drug Manufacturers - General | Switzerland |
| 6.53% | $147 B | 3359 | $274.03 | $920.47 K | Healthcare | Drug Manufacturers - General | United States |
| 5.94% | $211 B | 12 K | $68.06 | $849.18 K | Healthcare | Drug Manufacturers - General | United Kingdom |
| 5.37% | $350 B | 5107 | $145.25 | $741.79 K | Healthcare | Drug Manufacturers - General | United States |
US BANK MMDA - USBGFS 7 06/01/2031 | 5.29% | - | 740 K | | | | | |
| 5.07% | $34 B | 2880 | $266.55 | $767.66 K | Healthcare | Biotechnology | United States |
| 4.87% | $148 B | 26 K | $26.13 | $677.07 K | Healthcare | Drug Manufacturers - General | United States |
| 4.85% | $5 B | 23 K | $30.17 | $694.91 K | Healthcare | Drug Manufacturers - Specialty & Generic | Ireland |
| 4.70% | $242 B | 6718 | $95.73 | $643.11 K | Healthcare | Drug Manufacturers - General | United States |
| 3.51% | $75 B | 720 | $680.99 | $490.31 K | Healthcare | Biotechnology | United States |
| 3.13% | $21 B | 3119 | $142.74 | $445.21 K | Healthcare | Drug Manufacturers - General | United States |
| 3.06% | $4 B | 11 K | $44.50 | $469.78 K | Healthcare | Biotechnology | Switzerland |
| 2.80% | $5 B | 12 K | $32.49 | $405.35 K | Healthcare | Biotechnology | United States |
| 2.69% | $68 B | 11 K | $33.40 | $376.25 K | Healthcare | Drug Manufacturers - General | United Kingdom |
| 1.61% | $2 B | 9597 | $26.45 | $253.84 K | Healthcare | Biotechnology | United States |
| 1.37% | $869 M | 14 K | $12.59 | $181.25 K | Healthcare | Biotechnology | United Kingdom |
| 1.04% | $856 M | 14 K | $12.51 | $180.09 K | Healthcare | Biotechnology | United States |
| 0.98% | $1 B | 14 K | $11.10 | $159.79 K | Healthcare | Biotechnology | United States |
| 0.93% | $42 B | 14 K | $9.30 | $130.96 K | Healthcare | Drug Manufacturers - Specialty & Generic | United Kingdom |
| 0.81% | $255 M | 26 K | $4.38 | $113.49 K | Healthcare | Biotechnology | United States |
| 0.76% | $48 M | 29 K | $4.48 | $128.98 K | Healthcare | Biotechnology | United States |
| 0.61% | - | 1920 | | | | | |
| 0.58% | $39 B | 960 | $85.65 | $82.22 K | Healthcare | Health Information Services | United States |
| 0.48% | $77 M | 54 K | $1.22 | $65.57 K | Healthcare | Biotechnology | United States |
| 0.32% | $126 M | 17 K | $2.44 | $42.15 K | Healthcare | Biotechnology | United States |
| 0.29% | $13 B | 3572 | $11.25 | $40.17 K | Healthcare | Drug Manufacturers - Specialty & Generic | United States |
| 0.28% | $112 M | 32 K | $1.36 | $43.07 K | Healthcare | Biotechnology | United States |
| 0.26% | - | 36 K | | | | | |
| 0.25% | $409 M | 19 K | $1.95 | $37.43 K | Healthcare | Biotechnology | United States |
| 0.14% | $536 M | 12 K | $1.82 | $20.96 K | Healthcare | Medical Devices | United States |
| 0.11% | $77 M | 1822 | $7.96 | $14.50 K | Healthcare | Biotechnology | United States |
| 0.08% | $4 M | 3886 | $2.62 | $10.19 K | Healthcare | Biotechnology | United States |
| 0.07% | $67 M | 2304 | $3.95 | $9100.80 | Healthcare | Biotechnology | Ireland |
| 0.00% | - | 24 K | | | | | |
